Approvals/TGA/EYLEA aflibercept (rch) 40 mg/mL solution for intravitreal injection pre-filled syringe

Approved

STANDARD

EYLEA aflibercept (rch) 40 mg/mL solution for intravitreal injection pre-filled syringe

Bayer Australia Ltd🇦🇺 Therapeutic Goods Administration

Approval Id: 45d9b60bf42eb75a
Product Name: EYLEA aflibercept (rch) 40 mg/mL solution for intravitreal injection pre-filled syringe
Artg Id: 180860
Artg Name: EYLEA aflibercept (rch) 40 mg/mL solution for intravitreal injection pre-filled syringe
Sponsor: Bayer Australia Ltd
Company Detail Path: /organization/bayer-australia-ltd
Artg Date: 2012-03-07
Registration Type: Medicine
Therapeutic Good Type: Medicine
Licence Status: A
Licence Category: RE
Consumer Medicine Info: https://medical-cdn.nocode.com/drug_tga/f700f5468cf1363cd5c250a8a12d5132.pdf
Product Information: https://medical-cdn.nocode.com/drug_tga/f1f0b987fec443eb38e4d66462a681f8.pdf

Approved

Agency

TGA

Country

🇦🇺

Approval Date

May 29, 2025

Approval ID

45d9b60bf42eb75a

Type

Standard